Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Lung Cancer Therapeutics Market Report 2017-2022: Key Players are Pfizer, Ventana, Roche, Genentech, Glaxosmith, Agennix & Boehringer - Research and Markets

Research and Markets
Posted on: 05 Sep 17

The "Global Lung Cancer Therapeutics Market Growth, Trends & Forecasts 2017 - 2022" report has been added to Research and Markets' offering.

The Global market for Lung Cancer Therapeutics is expected to reach $8.5 billion by the end of 2020 growing at a CAGR of around 6% from 2014 to 2021.

Lung Cancer is the lethal lung tumor portrayed by the undisciplined growth of cells in the lung tissues. Cigarette smoking is the principal risk factor for the development of lung cancer. Prolonged exposure to tobacco smoke can also cause lung cancer. The interpretation of lung cancer is confirmed by biopsy which is carried out using bronchoscopy or CT-guidance. The two different types of lung cancer are small cell lung cancer & non-small cell lung cancer. Treatment of lung cancer can be done by chemotherapy, radiotherapy, surgery, etc.

The largest number of cancer deaths in both men and women is because of lung cancer. The lung cancer therapeutics market is segmented on the basis of Chemotherapy, Drugs, Radiotherapy (External beam radiotherapy, Internal radiotherapy and Systemic radiotherapy) and Region (North America, Europe, Asia Pacific and Rest of the World).

Companies Mentioned:

  • Pfizer
  • Ventana
  • Roche
  • Genentech
  • Glaxosmith
  • Agennix
  • Boehringer

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Porters Five Force Analysis

5. Market Segmentation

6. Competitive Landscape

7. Company Profiles

For more information about this report visit

View source version on

Business Wire

Last updated on: 05/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.